Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome is a research paper published in ACS Pharmacology & Translational Science (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Health and Medical Research Council
Grant: APP1072113
National Health and Medical Research Council
Grant: APP1080405
National Health and Medical Research Council
Grant: APP1126378
National Health and Medical Research Council
Grant: APP1136889
National Health and Medical Research Council
Grant: APP1139366
National Institutes of Health
Grant: P30 CA008748
National Institutes of Health
Grant: R01 EB029769
University of Queensland
Grant: N/A
Australian Research Council (ARC)
Grant: FT190100482
ARC Future Fellowships - Grant ID: FT190100482
National Health and Medical Research Council (NHMRC)
Grant: 1126378
Identifying the underlying causes of chronic visceral pain and discovering novel therapeutic treatments
National Health and Medical Research Council (NHMRC)
Grant: 1136889
Venoms to drugs: translating venom peptides into human therapeutics
National Institutes of Health
Grant: 5R01EB029769-04
Development and validation of an intraoperative imaging agent for the peripheral nervous system
National Health and Medical Research Council (NHMRC)
Grant: 1072113
Discovery and development of better pain treatments
National Health and Medical Research Council (NHMRC)
Grant: 1080405
Understanding how toxins interact with lipid membranes and ion channels
Australian Research Council (ARC)
Grant: FT160100055
ARC Future Fellowships - Grant ID: FT160100055
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
Australian Research Council (ARC)
Grant: CE200100012
ARC Centres of Excellence - Grant ID: CE200100012
National Health and Medical Research Council (NHMRC)
Grant: 1139366
Silencing visceral nociceptors by targeting NaV1.1: A novel therapeutic approach for treating Irritable Bowel Syndrome
FWCI
1.41
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals